Procedure for Stability Testing of Drug Products in Extreme Conditions
1) Purpose
The purpose of this SOP is to establish a procedure for conducting stability studies for drug products under extreme conditions in compliance with regulatory guidelines. This ensures that drug products maintain their quality, safety, and efficacy in various challenging environments.
2) Scope
This SOP applies to all personnel involved in the stability testing of drug products exposed to extreme conditions, including formulation development, quality control, and regulatory affairs teams.
3) Responsibilities
Formulation Development Team: Responsible for developing formulations designed to withstand extreme conditions.
Stability Study Team: Responsible for conducting stability studies under extreme conditions according to approved protocols.
Regulatory Affairs Team: Responsible for ensuring compliance with regulatory requirements and submitting stability data to authorities.
4) Procedure
4.1 Protocol Development
4.1.1 Develop a stability testing protocol that includes conditions such as extreme temperatures
(hot and cold), humidity, and light exposure.4.1.2 Define storage conditions and testing intervals (e.g., 0, 3, 6, 12 months) according to regulatory guidelines.
4.2 Sample Preparation and Storage
4.2.1 Prepare samples in their final packaging for stability testing, ensuring packaging is suitable for extreme conditions.
4.2.2 Store samples under specified extreme conditions, with continuous monitoring
4.3 Conducting Stability Tests
4.3.1 Perform stability tests at all required intervals, evaluating physical, chemical, and microbiological properties under extreme conditions.
4.3.2 Document all data accurately and ensure compliance with the approved protocol.
4.4 Data Analysis and Reporting
4.4.1 Analyze stability data to detect any trends or deviations that could impact product quality under extreme conditions.
4.4.2 Prepare a comprehensive stability report for regulatory submission, detailing all findings and conclusions.
5) Abbreviations, if any
QA: Quality Assurance
6) Documents, if any
6.1 Stability testing protocols
6.2 Data sheets
6.3 Stability reports
7) Reference, if any
FDA Guidance for Industry: Stability Testing of Drug Products in Extreme Conditions
8) SOP Version
Version 1.0

